DAVOS – In this snow-covered Alpine town where the world’s rich, powerful and elite met in January for the World Economic Forum, a quiet but consequential shift in thinking about dementia research crystallized – one with the potential to shape political engagements and research investments for the coming decade.  Long treated as a disease primarily […] Continue reading ->
Argentina took a step backwards last month when it revoked key guidelines that defined what could – and could not – be patented in its pharmaceutical sector.  For more than a decade, Argentina’s patentability guidelines have helped prevent pharmaceutical monopolies, enabling timely competition to enter the market, lowering prices of medical tools, and improving people’s […] Continue reading ->
Vaping is likely to cause oral and lung cancer, according to a comprehensive review of over 100 studies of the effects of nicotine-based e-cigarettes, published this week in the journal, Carcinogenesis. Carcinogenicity was evident in human studies that monitored biomarkers of harm, including DNA damage, oxidative stress, and “epigenetic change and inflammation in oral and […] Continue reading ->
Cervical cancer should no longer be killing women. It is one of the few cancers that we already know how to prevent, detect early, and treat effectively.  Yet it remains the fourth most common cancer among women worldwide, causing around 600,000 new cases and 340,000 deaths each year.  The tragedy is not just the scale […] Continue reading ->
From stalled Pathogen Access and Benefit Sharing (PABS) negotiations to failing consensus in global climate policies, United Nations structures face a profound crisis. Diplomats are currently being forced to explore alternative governance models to bridge the disconnect between sluggish, power-driven diplomacy and the rapid, equitable action required in health and climate crises. This institutional rupture […] Continue reading ->
Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform  aimed at accelerating drug discovery, thanks to a partnership between  Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading ->
With no agreement in sight, World Health Organization (WHO) member states curtailed talks on the Pandemic Agreement annex five hours earlier than scheduled on Saturday night, resolving to meet again within a month for a further five days of negotiations. Member states will reconvene between 27 April and 1 May to negotiate further on the […] Continue reading ->